168 related articles for article (PubMed ID: 30119628)
1. Healthcare reimbursement costs of children with type 1 diabetes in the Netherlands, a observational nationwide study (Young Dudes-4).
Spaans EAJM; van Dijk PR; Groenier KH; Brand PLP; Kleefstra N; Bilo HJG
BMC Endocr Disord; 2018 Aug; 18(1):57. PubMed ID: 30119628
[TBL] [Abstract][Full Text] [Related]
2. Seasonality of diagnosis of type 1 diabetes mellitus in the Netherlands (Young Dudes-2).
Spaans EA; van Dijk PR; Groenier KH; Brand PL; Reeser MH; Bilo HJ; Kleefstra N
J Pediatr Endocrinol Metab; 2016 Jun; 29(6):657-61. PubMed ID: 27008693
[TBL] [Abstract][Full Text] [Related]
3. Thyroid Disease and Type 1 Diabetes in Dutch Children: A Nationwide Study (Young Dudes-3).
Spaans E; Schroor E; Groenier K; Bilo H; Kleefstra N; Brand P
J Pediatr; 2017 Aug; 187():189-193.e1. PubMed ID: 28583704
[TBL] [Abstract][Full Text] [Related]
4. The incidence of type 1 diabetes is still increasing in the Netherlands, but has stabilised in children under five (Young DUDEs-1).
Spaans EA; Gusdorf LM; Groenier KH; Brand PL; Veeze HJ; Reeser HM; Bilo HJ; Kleefstra N
Acta Paediatr; 2015 Jun; 104(6):626-9. PubMed ID: 25640447
[TBL] [Abstract][Full Text] [Related]
5. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.
Giorda CB; Rossi MC; Ozzello O; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Romeo F; Lucisano G; Nicolucci A;
Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):209-216. PubMed ID: 28017523
[TBL] [Abstract][Full Text] [Related]
6. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
[TBL] [Abstract][Full Text] [Related]
7. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
[TBL] [Abstract][Full Text] [Related]
8. High direct costs of medical care in patients with Type 1 diabetes attending a referral clinic in a government-funded hospital in Northern India.
Katam KK; Bhatia V; Dabadghao P; Bhatia E
Natl Med J India; 2016; 29(2):64-7. PubMed ID: 27586208
[TBL] [Abstract][Full Text] [Related]
9. Increasing incidence of type 1 diabetes among Korean children and adolescents: analysis of data from a nationwide registry in Korea.
Kim JH; Lee CG; Lee YA; Yang SW; Shin CH
Pediatr Diabetes; 2016 Nov; 17(7):519-524. PubMed ID: 26420382
[TBL] [Abstract][Full Text] [Related]
10. A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands.
de Groot S; Enters-Weijnen CF; Geelhoed-Duijvestijn PH; Kanters TA
BMJ Open; 2018 Mar; 8(3):e019864. PubMed ID: 29581204
[TBL] [Abstract][Full Text] [Related]
11. First report on the nationwide incidence of type 1 diabetes and ketoacidosis at onset in children in Serbia: a multicenter study.
Vukovic R; Jesic MD; Vorgucin I; Stankovic S; Folic N; Milenkovic T; Sajic S; Katanic D; Zivic S; Markovic S; Soldatovic I
Eur J Pediatr; 2018 Aug; 177(8):1155-1162. PubMed ID: 29774417
[TBL] [Abstract][Full Text] [Related]
12. Social economic costs of type 1 diabetes mellitus in pediatric patients in Spain: CHRYSTAL observational study.
López-Bastida J; López-Siguero JP; Oliva-Moreno J; Perez-Nieves M; Villoro R; Dilla T; Merino M; Jiang D; Aranda-Reneo I; Reviriego J; Vázquez LA
Diabetes Res Clin Pract; 2017 May; 127():59-69. PubMed ID: 28319803
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological trends and direct costs of diabetes in a Northern Italy area: 2012 health administrative records analysis LHT n. 20 Verona.
Demurtas J; Alba N; Rigon G; Nesoti MV; Bovo C; Vaona A
Prim Care Diabetes; 2017 Dec; 11(6):570-576. PubMed ID: 28663023
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database.
Tuppin P; Rivière S; Rigault A; Tala S; Drouin J; Pestel L; Denis P; Gastaldi-Ménager C; Gissot C; Juillière Y; Fagot-Campagna A
Arch Cardiovasc Dis; 2016; 109(6-7):399-411. PubMed ID: 27079468
[TBL] [Abstract][Full Text] [Related]
15. The cost of type 1 diabetes: a nationwide multicentre study in Brazil.
Cobas RA; Ferraz MB; Matheus AS; Tannus LR; Negrato CA; Antonio de Araujo L; Dib SA; Gomes MB;
Bull World Health Organ; 2013 Jun; 91(6):434-40. PubMed ID: 24052680
[TBL] [Abstract][Full Text] [Related]
16. [Reduction of Treatment Duration in Periprosthetic Infection with a Fast-Track Concept Is Economically Not Feasible].
Lieb E; Hanstein T; Schuerings M; Trampuz A; Perka C
Z Orthop Unfall; 2015 Dec; 153(6):618-23. PubMed ID: 26468925
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing the economic costs associated with type 1 and type 2 diabetes.
Dall TM; Mann SE; Zhang Y; Quick WW; Seifert RF; Martin J; Huang EA; Zhang S
Popul Health Manag; 2009 Apr; 12(2):103-10. PubMed ID: 19361253
[TBL] [Abstract][Full Text] [Related]
18. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W
Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
[TBL] [Abstract][Full Text] [Related]
19. Frequency of purchase and associated costs of assistive technology for Washington State Medicaid program enrollees with spina bifida by age.
Bamer AM; Connell FA; Dudgeon BJ; Johnson KL
Disabil Health J; 2010 Jul; 3(3):155-61. PubMed ID: 21122780
[TBL] [Abstract][Full Text] [Related]
20. Healthcare expenditure and technology use in pediatric diabetes care.
de Vries SAG; Bak JCG; Verheugt CL; Stangenberger VA; Mul D; Wouters MWJM; Nieuwdorp M; Sas TCJ
BMC Endocr Disord; 2023 Apr; 23(1):72. PubMed ID: 37029362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
